State Street
IMNM icon

State Street’s Immunome IMNM Stock Holding History

State Street’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$116M Buy
5,494,625
+94,724
+2% +$2.03M ﹤0.01% 1385
2026
Q1 		$118M Buy
5,399,901
+1,531,901
+40% +$34.1M ﹤0.01% 1285
2025
Q4 		$83.1M Buy
3,868,000
+1,064,027
+38% +$18.7M ﹤0.01% 1461
2025
Q3 		$32.8M Buy
2,803,973
+283,057
+11% +$2.82M ﹤0.01% 1966
2025
Q2 		$23.4M Sell
2,520,916
-119,527
-5% -$980K ﹤0.01% 2103
2025
Q1 		$17.8M Buy
2,640,443
+513,608
+24% +$4.93M ﹤0.01% 2201
2024
Q4 		$22.6M Sell
2,126,835
-60,631
-3% -$733K ﹤0.01% 2162
2024
Q3 		$32M Sell
2,187,466
-176,768
-7% -$2.51M ﹤0.01% 1933
2024
Q2 		$28.6M Buy
2,364,234
+2,163,543
+1,078% +$33.8M ﹤0.01% 1973
2024
Q1 		$4.95M Buy
200,691
+170,100
+556% +$3.45M ﹤0.01% 2929
2023
Q4 		$327K Buy
30,591
+1,000
+3% +$8.31K ﹤0.01% 3753
2023
Q3 		$247K Hold
29,591
– – ﹤0.01% 3874
2023
Q2 		$234K Hold
29,591
– – ﹤0.01% 3948
2023
Q1 		$148K Hold
29,591
– – ﹤0.01% 4173
2022
Q4 		$65.1K Hold
29,591
– – ﹤0.01% 4489
2022
Q3 		$131K Hold
29,591
– – ﹤0.01% 4341
2022
Q2 		$95K Hold
29,591
– – ﹤0.01% 4556
2022
Q1 		$168K Buy
29,591
+2,591
+10% +$19.4K ﹤0.01% 4445
2021
Q4 		$350K Buy
27,000
+14,300
+113% +$255K ﹤0.01% 4133
2021
Q3 		$309K Buy
+12,700
New +$222K ﹤0.01% 4182
2021
Q2 		– Sell
-32,550
Closed -$1.1M – 4480
2021
Q1 		$1.1M Buy
+32,550
New +$809K ﹤0.01% 3603

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street's IMNM Position: Q2 2026 in Review

State Street increased its Immunome (IMNM) stake by 1.8% in Q2 2026, buying an estimated $2.03M and bringing the position to 5,494,625 shares worth $116M. The position accounts for ﹤0.01% of the portfolio, ranked #1385.

State Street first reported a position in IMNM in Q1 2021 and has held it in 21 quarters since. The position peaked at $118M in Q1 2026. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • State Street held 5,494,625 shares of Immunome worth $116M as of Q2 2026.
  • State Street bought 94,724 Immunome shares in Q2 2026, an estimated $2.03M.
  • Immunome made up ﹤0.01% of State Street's portfolio in Q2 2026, its #1385 holding.
  • State Street first reported a position in Immunome in Q1 2021 and has held it in 21 quarters since.
  • State Street's Immunome position peaked at $118M in Q1 2026.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.